Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 451 - 455 of 455 results

First page
Previous page
46
Next page disabled
Next page disabled

NEDOSIRAN SODIUM

EGR9KYM536

Sequence Search

Status:

US Approved Rx (2023)

Source:

NDA215842

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215842

First approved in 2023

Source:

NDA215842

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215842

Class:

NUCLEIC ACID

EPLONTERSEN SODIUM

WSP2DHR2BD

Sequence Search

Status:

US Approved Rx (2023)

Source:

NDA217388

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217388

First approved in 2023

Source:

NDA217388

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217388

Class:

NUCLEIC ACID

TOFERSEN SODIUM

5YL205692C

Sequence Search

Status:

US Approved Rx (2023)

Source:

NDA215887

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215887

First approved in 2023

Source:

NDA215887

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215887

Class:

NUCLEIC ACID

AGATOLIMOD SODIUM

I4Z5C8FM6H

Sequence Search

Status:

Possibly Marketed Outside US

Source:

BLA125761

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4f29180-7c76-40ac-9341-cf62702c4090

First approved in 2023

Source:

BLA125761

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4f29180-7c76-40ac-9341-cf62702c4090

Class:

NUCLEIC ACID

PENTAPEPTIDE-34 TRIFLUOROACETATE

SQS1FA1FGW

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f485c51a-b147-7b2b-e053-2995a90a876d

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f485c51a-b147-7b2b-e053-2995a90a876d

Class:

CONCEPT

Nucleic Acid

NEDOSIRAN SODIUM

Nucleic Acid

EPLONTERSEN SODIUM

Nucleic Acid

TOFERSEN SODIUM

Nucleic Acid

AGATOLIMOD SODIUM

Concept

PENTAPEPTIDE-34 TRIFLUOROACETATE

Showing 451 - 455 of 455 results

First page
Previous page
46
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1